FEops HEARTguide vs Viz RV/LV
AI Verdict
Choose FEops HEARTguide if…
Choose FEops HEARTguide if you are a cardiologist or cardiothoracic surgeon focused on optimizing pre-operative planning for complex structural heart interventions like TAVI or TMVR. This platform is ideal for leveraging patient-specific digital twins and predictive simulations to precisely size and position devices, aiming to enhance procedural success and patient safety.
View FEops HEARTguide →Choose Viz RV/LV if…
Choose Viz RV/LV if your primary need is rapid and automated risk stratification for patients with suspected pulmonary embolism. This AI algorithm excels at quickly measuring the RV/LV ratio from CTPA scans, enabling emergency medicine, pulmonology, and radiology teams to promptly identify high-risk cases and facilitate efficient care coordination.
View Viz RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FEops HEARTguide | Viz RV/LV |
|---|---|---|
| Deployment | Cloud Based platform | Cloud-based |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz RV/LVTool B, Viz RV/LV, emphasizes automation for rapid measurements and integrates seamlessly into the broader Viz PE Solution, providing AI-powered alerts and a mobile DICOM viewer for quick, actionable insights. This focus on speed, automation, and integrated care coordination for time-sensitive conditions suggests a higher degree of usability for rapid clinical decision-making. Tool A, while offering powerful interactive planning, involves more detailed user interaction for complex procedures.
Clinical Value
TieBoth tools offer significant and distinct clinical value. Tool A, FEops HEARTguide, directly improves patient outcomes in structural heart procedures by optimizing device sizing and positioning through predictive simulations. Tool B, Viz RV/LV, provides crucial rapid risk stratification for pulmonary embolism, enabling faster interventions for a life-threatening condition. Both are critical for patient care in their respective specialties.
Pricing & Value
TieNeither Tool A nor Tool B provides publicly available pricing information, stating 'contact for pricing' or 'not publicly available.' Both are enterprise-level solutions, and their value proposition would be highly dependent on specific institutional needs, negotiated contracts, and the realized clinical and operational benefits. Without transparent pricing, a direct comparison of pricing and value is not possible.
Enterprise Readiness
Viz RV/LVBoth tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and cloud-based deployment. However, Tool B, Viz RV/LV, explicitly mentions having a Business Associate Agreement (BAA) and is a 'seamless component of the Viz PE Solution,' which includes AI-powered alerts and a HIPAA-compliant communication platform for care coordination. This indicates a more comprehensive and integrated enterprise ecosystem for workflow and communication.
Innovation
FEops HEARTguideTool A, FEops HEARTguide, leverages 'digital twin' technology and 'predictive simulations' to create patient-specific replicas for optimizing structural heart procedures. This approach represents a higher degree of innovation by moving beyond automated detection to proactive, personalized outcome prediction and procedural guidance. While Tool B's automation and care coordination are valuable, the core AI for image analysis is a more established application.
Support & Docs
Viz RV/LVWhile both enterprise solutions would offer support, Viz.ai, the company behind Tool B, is a larger organization with a broader suite of AI solutions deployed across numerous hospitals. This suggests a more extensive, structured, and readily available support and documentation ecosystem, including dedicated customer success teams and technical support, compared to a more specialized company like FEops.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FEops HEARTguide | Viz RV/LV |
|---|---|---|
| Name | FEops HEARTguide | Viz RV/LV |
| Company | FEops NV | Viz.ai |
| Description | FEops HEARTguideu2122 is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning for improved patient outcomes. | Viz RV/LV by Viz.ai is an FDA-cleared AI algorithm that automates right and and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution. |
| Key Features | Predictive simulation technology; AI-based anatomical measurements; Digital twin technology for patient-specific replicas; Cloud-based platform with anytime, anywhere access; DICOM interface for CT scan upload; Semi-automatic identification and measurement of anatomical landmarks; Interactive 2D and 3D viewer; Evaluation of device sizing and positioning pre-operatively | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement; Analysis of volumetric CTPA acquisitions; AI algorithm for identification and measurement of heart ventricles; Provides annotated images showing ventricular measurements; Seamless component of the Viz PE Solution for suspected pulmonary embolism detection; AI-powered alerts and notifications to care teams; High-fidelity mobile DICOM image viewer; HIPAA-compliant communication platform for care coordination |
| Specialties | Cardiology, Cardiothoracic Surgery | Emergency Medicine, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring FEops HEARTguide and Viz RV/LV.